ArticleMedicina (Kaunas, Lithuania)2026
The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study.
Huai-Lung Chang, Ling-Uei Wang, Tzu-Lun Huang, Pei-Yao Chang, Wei-Ting Ho, Yung-Ray Hsu, Fang-Ting Chen, Yun-Ju Chen, Cheng-Hung Dixson Lin, Jia-Kang Wang
Abstract read
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Huai-Lung ChangDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Ling-Uei WangDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Tzu-Lun HuangDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Pei-Yao ChangDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Wei-Ting HoDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Yung-Ray HsuDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Fang-Ting ChenDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.ORCID 0000-0002-6534-7246 Yun-Ju ChenDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.
Cheng-Hung Dixson LinDepartment of Electrical Engineering, Yuan Ze University, Taoyuan City 320315, Taiwan.ORCID 0000-0001-8373-2271 Jia-Kang WangDepartment of Ophthalmology, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.ORCID 0000-0003-3157-3613 Funding
National Science and Technology Council NSTC 114-2221-E-003-037
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Macular DegenerationAgedAged, 80 and overAngiogenesis InhibitorsAntibodies, BispecificFemaleHumansIntravitreal InjectionsMaleMiddle AgedPolypoidal Choroidal VasculopathyRetrospective StudiesTreatment OutcomeVascular Endothelial Growth Factor AVisual AcuityAngiogenesis InhibitorsAntibodies, BispecificfaricimabVascular Endothelial Growth Factor Afaricimabneovascular age-related macular degenerationpolypoidal choroidal vasculopathy
Identifiers
PMID42195115
PMCPMC13208648
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390